Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor with an IC50 of 0.9 nM and minimal inhibition against Bcl-xl (IC50 > 1000 nM). It is used in cancer research related to Bcl-2 family protein overexpression, particularly in hematologic malignancies like acute lymphoid leukemia, while minimizing the risk of side effects such as thrombocytopenia [1] by sparing Bcl-xl.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 
| Description | Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor with an IC50 of 0.9 nM and minimal inhibition against Bcl-xl (IC50 > 1000 nM). It is used in cancer research related to Bcl-2 family protein overexpression, particularly in hematologic malignancies like acute lymphoid leukemia, while minimizing the risk of side effects such as thrombocytopenia [1] by sparing Bcl-xl.  | 
| Targets&IC50 |  BCL-XL:>1000 nM, Bcl-2:0.9 nM  | 
| In vitro | Bcl-2-IN-11 (compound 6) inhibits the proliferation of RS4;11 acute lymphoblastic cells with an IC50 of 2.37 nM [1].  | 
| Molecular Weight | 902.43 | 
| Formula | C45H49ClFN7O8S | 
| Cas No. | 2760536-88-5 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.